NWAG
BSX icon

Net Worth Advisory Group’s Boston Scientific BSX Stock Holding History

Net Worth Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,690
Closed -$357K – 418
2026
Q1 		$357K Buy
5,690
+1,036
+22% +$82.9K 0.07% 263
2025
Q4 		$444K Sell
4,654
-757
-14% -$74.2K 0.09% 228
2025
Q3 		$528K Sell
5,411
-595
-10% -$61.6K 0.15% 157
2025
Q2 		$645K Sell
6,006
-263
-4% -$26.6K 0.14% 156
2025
Q1 		$632K Buy
6,269
+1,802
+40% +$181K 0.2% 116
2024
Q4 		$399K Buy
4,467
+12
+0.3% +$1.06K 0.12% 199
2024
Q3 		$373K Buy
+4,455
New +$351K 0.11% 212

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Net Worth Advisory Group's BSX Position: Q2 2026 in Review

Net Worth Advisory Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,690 shares — an estimated $357K sold.

Net Worth Advisory Group first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $645K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Net Worth Advisory Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Net Worth Advisory Group sold 5,690 Boston Scientific shares in Q2 2026, an estimated $357K.
  • Net Worth Advisory Group first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Net Worth Advisory Group's Boston Scientific position peaked at $645K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.